iBio
IBIO
9 hedge funds and large institutions have $937K invested in iBio in 2014 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
61% more capital invested
Capital invested by funds: $581K → $937K (+$356K)
0% more funds holding
Funds holding: 9 → 9 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$97.6K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$48.8K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.76K |
| 4 |
Millennium Management
New York
|
+$7.32K |
| 5 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
+$2.44K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$52K |
| 2 |
U
UBS
Zurich,
Switzerland
|
-$22K |
| 3 |
CM
Churchill Management
Los Angeles,
California
|
-$8K |
| 4 |
Morgan Stanley
New York
|
-$2K |
| 5 |
Citigroup
New York
|
-$1K |
IBIO Hedge Fund Activity: Q3 2014 in Review
9 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q3 2014, worth a combined $937K — up 61% from $581K a quarter earlier.
Fund positioning in IBIO was balanced in Q3 2014: 3 funds opened new positions, 3 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $97.6K. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $52K sold.
- 9 institutional investors held iBio (IBIO) as of Q3 2014, unchanged from Q2 2014.
- Funds reported $937K of iBio stock for Q3 2014, up 61% quarter-over-quarter.
- 3 funds opened new iBio positions in Q3 2014 and 3 closed out, a net change of 0 holders.
- The largest iBio buyer in Q3 2014 was Geode Capital Management, an estimated $97.6K added.
- The largest iBio seller in Q3 2014 was Dimensional Fund Advisors, an estimated $52K sold.
Based on aggregated 13F filings for Q3 2014.